C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Top Cited Papers
Open Access
- 18 July 2001
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 286 (3), 327-334
- https://doi.org/10.1001/jama.286.3.327
Abstract
Type 2 diabetes mellitus (DM) is estimated to affect 15 million Americans, is dramatically increasing in incidence, and is associated with an augmented risk for cardiovascular disease, especially among women.1-3 Because of the resultant macrovascular and microvascular injury typical of this disease, the economic and functional burdens are greatest during mid-to-late adulthood. Compounding these issues, as many as one third of individuals with type 2 DM are undiagnosed, and approximately 20% have diabetic retinopathy or evidence of systemic vasculopathy at clinical presentation.4Keywords
This publication has 30 references indexed in Scilit:
- Association between C-reactive protein and features of the metabolic syndrome: a population-based study.Diabetes Care, 2000
- Body mass index, diabetes, and C-reactive protein among U.S. adults.Diabetes Care, 1999
- Is Type II diabetes mellitus a disease of the innate immune system?Diabetologia, 1998
- Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994Diabetes Care, 1998
- NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome XDiabetologia, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- The association of leukocyte count, fibrinogen and c-reactive protein with vascular risk factors and ischemic vascular diseasesThrombosis Research, 1996
- Onset of NIDDM occurs at Least 4–7 yr Before Clinical DiagnosisDiabetes Care, 1992
- Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approachDiabetes, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988